BIODESIX INC Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Biodesix Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2025.
  • Biodesix Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$8.72M, a 15% increase year-over-year.
  • Biodesix Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$39.5M, a 9.77% increase year-over-year.
  • Biodesix Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$42.9M, a 17.7% increase from 2023.
  • Biodesix Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$52.1M, a 20.3% increase from 2022.
  • Biodesix Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$65.4M, a 51.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

BIODESIX INC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$39.5M -$8.72M +$1.54M +15% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-03
Q2 2025 -$41.1M -$11.5M -$660K -6.11% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-03
Q1 2025 -$40.4M -$11.1M +$2.51M +18.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-03
Q4 2024 -$42.9M -$8.25M +$888K +9.72% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 -$43.8M -$10.3M +$691K +6.31% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 -$44.5M -$10.8M +$2.55M +19.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-03
Q1 2024 -$47.1M -$13.6M +$5.09M +27.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-03
Q4 2023 -$52.1M -$9.14M +$11.2M +55.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 -$63.3M -$10.9M +$2.75M +20.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-01
Q2 2023 -$66.1M -$13.4M +$2.47M +15.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-01
Q1 2023 -$68.6M -$18.7M -$3.12M -20% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-01
Q4 2022 -$65.4M -$20.3M -$7.06M -53.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 -$58.4M -$13.7M -$2.19M -19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$56.2M -$15.8M -$4.42M -38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$51.8M -$15.6M -$8.63M -124% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$43.2M -$13.3M +$25.3M +65.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$68.5M -$11.5M -$2.67M -30.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$65.8M -$11.4M -$3.14M -37.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$62.7M -$6.96M +$2.75M +28.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$65.4M -$38.6M -$32.1M -492% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$33.3M -$8.85M +$756K +7.87% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$34.1M -$8.27M -$1.41M -20.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$32.7M -$9.71M -$1.96M -25.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$30.7M -$6.53M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$9.6M Jul 1, 2019 Sep 30, 2019 10-Q 2020-12-10
Q2 2019 -$6.86M Apr 1, 2019 Jun 30, 2019 10-Q 2020-12-10
Q1 2019 -$7.74M Jan 1, 2019 Mar 31, 2019 10-Q 2020-12-10

BIODESIX INC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$42.9M +$9.22M +17.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-03
2023 -$52.1M +$13.3M +20.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-03
2022 -$65.4M -$22.3M -51.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$43.2M +$22.3M +34.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 -$65.4M -$34.7M -113% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 -$30.7M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.